Sort   by:  
 Page size 
UnknownPhase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.
Not available
S-EPMC5946714 | biostudies-literature
ProteomicsThe Proteome analysis of Bacillus WR10 under iron deficiency
The proteome of Bacillus WR10 grown in iron sufficient and iron deficienct conditions
ORGANISM(S): Bacillus Altitudinis 
2022-01-10 | PXD030851 |
Sort   by:  
 Page size